ATE356144T1 - Regulatorische/entfaltende peptide von ezrin - Google Patents

Regulatorische/entfaltende peptide von ezrin

Info

Publication number: ATE356144T1
Authority: AT; Austria
Prior art keywords: ezrin; regulatory; developing peptides; peptides; developing
Prior art date: 1999-09-17

Application number

AT00962685T

Other languages

English (en)

Inventor

Rupert Donald Holms

Original Assignee

Rupert Donald Holms

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-17

Filing date

2000-09-15

Publication date

2007-03-15

2000-09-15 Application filed by Rupert Donald Holms filed Critical Rupert Donald Holms

2007-03-15 Application granted granted Critical

2007-03-15 Publication of ATE356144T1 publication Critical patent/ATE356144T1/de

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
102100020903 Ezrin Human genes 0.000 title 1
108010055671 ezrin Proteins 0.000 title 1
102000004196 processed proteins & peptides Human genes 0.000 title 1
230000001105 regulatory effect Effects 0.000 title 1
208000035473 Communicable disease Diseases 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
210000000987 immune system Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Animal Behavior & Ethology (AREA)
Genetics & Genomics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Toxicology (AREA)
Oncology (AREA)
Zoology (AREA)
Rehabilitation Therapy (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Hematology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cell Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AT00962685T 1999-09-17 2000-09-15 Regulatorische/entfaltende peptide von ezrin ATE356144T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9921881A GB2354241A (en)	1999-09-17	1999-09-17	Regulatory/unfolding peptides of ezrin

Publications (1)

Publication Number	Publication Date
ATE356144T1 true ATE356144T1 (de)	2007-03-15

Family

ID=10861009

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00962685T ATE356144T1 (de)	1999-09-17	2000-09-15	Regulatorische/entfaltende peptide von ezrin

Country Status (23)

Country	Link
US (1)	US6849596B1 (de)
EP (2)	EP1760090A1 (de)
JP (1)	JP2003511389A (de)
KR (1)	KR20010101017A (de)
CN (1)	CN100387619C (de)
AT (1)	ATE356144T1 (de)
AU (1)	AU770208B2 (de)
BR (1)	BR0007158A (de)
CA (1)	CA2348780A1 (de)
CY (1)	CY1106644T1 (de)
CZ (1)	CZ20011689A3 (de)
DE (1)	DE60033783T2 (de)
DK (1)	DK1131348T3 (de)
ES (1)	ES2283317T3 (de)
GB (1)	GB2354241A (de)
HU (1)	HUP0104254A3 (de)
NO (1)	NO20012417L (de)
NZ (1)	NZ511747A (de)
PL (1)	PL348635A1 (de)
PT (1)	PT1131348E (de)
RU (1)	RU2215005C2 (de)
WO (1)	WO2001025275A1 (de)
ZA (1)	ZA200103938B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0301879D0 (en) *	2003-01-27	2003-02-26	Regent Res Llp	HCV combination therapy
WO2007060440A2 (en) *	2005-11-23	2007-05-31	Regent Research L.L.P.	The use of peptides in anti-ulcer therapy
CN100455665C (zh) *	2006-11-21	2009-01-28	汕头大学医学院	人食管癌细胞ezrin基因上游转录调控元件
WO2009103312A1 (en) *	2008-02-19	2009-08-27	Ludwig-Maximilians-Universität	Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases
RU2580629C1 (ru) *	2015-05-15	2016-04-10	Федеральное государственное бюджетное учреждение "Научный центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации	Способ прогнозирования рецептивности эндометрия на основании оценки экспрессии и внутриклеточной локализации эзрина в эндометрии женщин с бесплодием и повторными неудачами программы эко
WO2016193285A1 (en) *	2015-06-01	2016-12-08	Nearmedic International Limited	Ezrin-derived peptides and pharmaceutical compositions thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2290293A (en) *	1994-06-08	1995-12-20	Rupert Donald Holms	Preparation which inhibits the autoimmune response in HIV, or SLE, patients
US6251586B1 (en) *	1995-10-02	2001-06-26	The United States Of America As Represented By The Department Of Health And Human Services	Epithelial protein and DNA thereof for use in early cancer detection
US6399584B1 (en) *	1998-03-18	2002-06-04	Institute Curie	Pharmaceutical composition containing ezrin mutated on tyrosine 353

1999
- 1999-09-17 GB GB9921881A patent/GB2354241A/en not_active Withdrawn
2000
- 2000-09-15 DK DK00962685T patent/DK1131348T3/da active
- 2000-09-15 JP JP2001528215A patent/JP2003511389A/ja not_active Withdrawn
- 2000-09-15 BR BR0007158-7A patent/BR0007158A/pt not_active IP Right Cessation
- 2000-09-15 PL PL00348635A patent/PL348635A1/xx unknown
- 2000-09-15 WO PCT/GB2000/003566 patent/WO2001025275A1/en not_active Ceased
- 2000-09-15 NZ NZ511747A patent/NZ511747A/xx unknown
- 2000-09-15 EP EP06009089A patent/EP1760090A1/de not_active Withdrawn
- 2000-09-15 AU AU74333/00A patent/AU770208B2/en not_active Ceased
- 2000-09-15 RU RU2001113277/04A patent/RU2215005C2/ru not_active IP Right Cessation
- 2000-09-15 US US09/856,070 patent/US6849596B1/en not_active Expired - Fee Related
- 2000-09-15 CZ CZ20011689A patent/CZ20011689A3/cs unknown
- 2000-09-15 DE DE60033783T patent/DE60033783T2/de not_active Expired - Fee Related
- 2000-09-15 EP EP00962685A patent/EP1131348B1/de not_active Expired - Lifetime
- 2000-09-15 ES ES00962685T patent/ES2283317T3/es not_active Expired - Lifetime
- 2000-09-15 CA CA002348780A patent/CA2348780A1/en not_active Abandoned
- 2000-09-15 KR KR1020017006187A patent/KR20010101017A/ko not_active Ceased
- 2000-09-15 PT PT00962685T patent/PT1131348E/pt unknown
- 2000-09-15 HU HU0104254A patent/HUP0104254A3/hu unknown
- 2000-09-15 CN CNB008022844A patent/CN100387619C/zh not_active Expired - Fee Related
- 2000-09-15 AT AT00962685T patent/ATE356144T1/de not_active IP Right Cessation
2001
- 2001-05-15 ZA ZA200103938A patent/ZA200103938B/en unknown
- 2001-05-16 NO NO20012417A patent/NO20012417L/no not_active Application Discontinuation
2007
- 2007-06-06 CY CY20071100749T patent/CY1106644T1/el unknown

Also Published As

Publication number	Publication date
EP1131348B1 (de)	2007-03-07
NZ511747A (en)	2004-03-26
CZ20011689A3 (cs)	2001-12-12
CA2348780A1 (en)	2001-04-12
ES2283317T3 (es)	2007-11-01
HUP0104254A3 (en)	2002-05-28
HUP0104254A2 (hu)	2002-04-29
NO20012417L (no)	2001-07-16
DE60033783D1 (de)	2007-04-19
GB9921881D0 (en)	1999-11-17
AU770208B2 (en)	2004-02-19
KR20010101017A (ko)	2001-11-14
BR0007158A (pt)	2001-07-31
CN1327450A (zh)	2001-12-19
CY1106644T1 (el)	2012-01-25
US6849596B1 (en)	2005-02-01
CN100387619C (zh)	2008-05-14
WO2001025275A9 (en)	2002-07-25
AU7433300A (en)	2001-05-10
WO2001025275A1 (en)	2001-04-12
GB2354241A (en)	2001-03-21
EP1131348A1 (de)	2001-09-12
NO20012417D0 (no)	2001-05-16
EP1760090A1 (de)	2007-03-07
JP2003511389A (ja)	2003-03-25
PL348635A1 (en)	2002-06-03
ZA200103938B (en)	2002-05-15
DE60033783T2 (de)	2007-11-15
DK1131348T3 (da)	2007-07-09
PT1131348E (pt)	2007-11-19
RU2215005C2 (ru)	2003-10-27

Legal Events

Date

Code

Title

Description

2007-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1131348

Country of ref document: EP

2009-06-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
FI956078A7 (fi)	1996-02-14	Järjestelmä veren virusten inaktivoimiseksi
FR12C0004I1 (de)	2012-02-24
NO933126D0 (no)	1993-09-02	Loeselige ligander for cd40
NO20014415L (no)	2001-11-12	Medisinske preparater til behandling av <alfa>-galaktosidase- A-defisiens
DE68912441D1 (de)	1994-03-03	Nichtessentielle Geflügelpockenvirus-Regionen.
DE60233955D1 (de)	2009-11-19	Spezifische bindungsmittel von human angiopoietin-2
FI923495A7 (fi)	1992-08-03	Peptidylderivat.
ID22977A (id)	1999-12-23	Konjugasi polietilen glikol-interferon alfa untuk terapi suatu infeksi
DE10399032I1 (de)	2004-01-29	Rekombinante Viren.
ATE110743T1 (de)	1994-09-15	Antikoagulierende peptide.
TR200002965T2 (tr)	2001-05-21	Enfeksiyonların terapötik ve profilaktik tedavisi için organofosforlu terkiplerin kullanımı
TR199501635A1 (tr)	1996-10-21	Solunum yolu ile alinan terapötik preparatlar.
DE3888086D1 (de)	1994-04-07	Rekombinantes Geflügelpockenvirus, Expressionsvektoren für heterologische Proteine und davon derivierte Geflügelvakzine.
TR199901949T2 (xx)	2000-01-21	Lemfositik t�m�rler i�in �areler.
DE69101683D1 (de)	1994-05-19	Rekombinantes Mareks-Krankheitsvirus.
ATE402713T1 (de)	2008-08-15	Genetisch manipulierte herpesviren zur behandlung von tumoren
DE69318136D1 (de)	1998-05-28	Sulfonsaeurederivate zur behandlung von viruserkrankungen
DE69530844D1 (de)	2003-06-26	Verfahren und substanzen gegen protozoen
DE3776999D1 (de)	1992-04-09	Mittel zur vorbeugung gegen pflanzenviruskrankheiten.
NO911429D0 (no)	1991-04-11	Stoffbehandling.
ATE356144T1 (de)	2007-03-15	Regulatorische/entfaltende peptide von ezrin
ATE201693T1 (de)	2001-06-15	Hämoregulierende peptide
NO913117D0 (no)	1991-08-09	Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO911430D0 (no)	1991-04-11	Stoffbehandlingsmetode.
FI965196A0 (fi)	1996-12-23	HIV-infektion yhdistelmähoito